Idiopathic Inflammatory Myopathy
What's New
Last Posted: Sep 02, 2023
- Leveraging Genomic and Bioinformatic Analysis to Enhance Drug Repositioning for Dermatomyositis.
Lalu Muhammad Irham, et al. Bioengineering (Basel, Switzerland) 2023 0 (8) - Human leukocyte antigen in Japanese patients with idiopathic inflammatory myopathy.
Furukawa Hiroshi, et al. Modern rheumatology 2019 0 (4) 696-702 - HLA Alleles Associated with Interstitial Lung Disease in North Americans with Idiopathic Inflammatory Myopathy.
Johnson Cheilonda, et al. American journal of respiratory and critical care medicine 2022 0 - Molecular markers of systemic autoimmune disorders: the expression of MHC-located HSP70 genes is significantly associated with autoimmunity development.
Mišunová Martina, et al. Clinical and experimental rheumatology 2016 0 (1) 33-42 - Association with HLA-DR?1 position 37 distinguishes juvenile dermatomyositis from adult-onset myositis.
Deakin Claire T, et al. Human molecular genetics 2022 0 (14) 2471-2481 - HLA-DRB1 allele and autoantibody profiles in Japanese patients with inclusion body myositis.
Oyama Munenori, et al. PloS one 2020 0 (8) e0237890 - The PTPN22 gene is associated with idiopathic inflammatory myopathy.
Maundrell Adam, et al. Muscle & nerve 2016 6 - Seasonality of birth patterns in an Australian cohort of patients with biopsy-confirmed idiopathic inflammatory myopathy.
Woodman R, et al. Internal medicine journal 2016 5 (5) 619-21 - Vitamin D receptor gene polymorphisms and haplotypes in Hungarian patients with idiopathic inflammatory myopathy.
Bodoki Levente, et al. BioMed research international 2015 0 809895 - Arthritis in idiopathic inflammatory myopathy: clinical features and autoantibody associations.
Klein Martin, et al. The Journal of rheumatology 2014 6 (6) 1133-9
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 03, 2024
- Content source: